论文部分内容阅读
目的探讨出血性卒中急性期并癫痫的临床治疗措施。方法回顾分析2007年2月至2010年12月出血性卒中急性期并癫痫的38例患者的临床资料。结果本组患者在治疗脑出血的同时,给予抗癫痫药物治疗,癫痫持续状态者用安定静脉注射治疗得到控制。其中11例在急性期2周内死于颅内高压、再出血、脑疝及上消化道出血。其余27例经抗癫痫治疗发作得到控制;通过本组治疗观察发现,出血性卒中后急性期癫痫发作出现早,发作频率高,且病死率高。结论出血性卒中急性期并癫痫的临床发生率较高,其危害较大。临床应积极治疗原发病,及时治疗早期癫痫发作,早期实施脑保护治疗,以预防癫痫发作,提高患者的生存率,改善患者的预后。
Objective To investigate the clinical treatment of hemorrhagic stroke with acute epilepsy. Methods The clinical data of 38 patients with acute hemorrhagic stroke and epilepsy from February 2007 to December 2010 were retrospectively analyzed. Results This group of patients in the treatment of cerebral hemorrhage at the same time, given anti-epileptic drug treatment, sustained-state epilepsy patients with stability and stability of the intravenous injection therapy was controlled. Eleven of them died of intracranial hypertension within 2 weeks of acute phase, rebleeding, hernia and upper gastrointestinal bleeding. The remaining 27 cases were controlled by the antiepileptic treatment; through the treatment of this group found that acute seizures after hemorrhagic stroke appear early, seizure frequency, and high mortality. Conclusion The incidence of acute epilepsy in hemorrhagic stroke is higher than that of epilepsy, which is more harmful. Clinical should actively treat the primary disease, timely treatment of early seizures, early brain protection treatment to prevent seizures, improve patient survival and improve patient prognosis.